406 related articles for article (PubMed ID: 25309512)
1. Molecular and cellular events mediating glomerular podocyte dysfunction and depletion in diabetes mellitus.
Anil Kumar P; Welsh GI; Saleem MA; Menon RK
Front Endocrinol (Lausanne); 2014; 5():151. PubMed ID: 25309512
[TBL] [Abstract][Full Text] [Related]
2. Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy.
Mukhi D; Nishad R; Menon RK; Pasupulati AK
Front Med (Lausanne); 2017; 4():102. PubMed ID: 28748185
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis.
Lenoir O; Jasiek M; Hénique C; Guyonnet L; Hartleben B; Bork T; Chipont A; Flosseau K; Bensaada I; Schmitt A; Massé JM; Souyri M; Huber TB; Tharaux PL
Autophagy; 2015; 11(7):1130-45. PubMed ID: 26039325
[TBL] [Abstract][Full Text] [Related]
4. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J
Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy.
Ziyadeh FN; Wolf G
Curr Diabetes Rev; 2008 Feb; 4(1):39-45. PubMed ID: 18220694
[TBL] [Abstract][Full Text] [Related]
6. Glomerular Endothelium and its Impact on Glomerular Filtration Barrier in Diabetes: Are the Gaps Still Illusive?
Ndisang JF
Curr Med Chem; 2018; 25(13):1525-1529. PubMed ID: 28685678
[TBL] [Abstract][Full Text] [Related]
7. Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?
Marshall CB
Am J Physiol Renal Physiol; 2016 Nov; 311(5):F831-F843. PubMed ID: 27582102
[TBL] [Abstract][Full Text] [Related]
8. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy.
Zhu WW; Chen HP; Ge YC; Xie HL; Zeng CH; Li LS; Liu ZH
Diabetes Res Clin Pract; 2009 Dec; 86(3):199-207. PubMed ID: 19815303
[TBL] [Abstract][Full Text] [Related]
10. From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.
Wolf G; Chen S; Ziyadeh FN
Diabetes; 2005 Jun; 54(6):1626-34. PubMed ID: 15919782
[TBL] [Abstract][Full Text] [Related]
11. Growth Hormone Induces Transforming Growth Factor-Beta-Induced Protein in Podocytes: Implications for Podocyte Depletion and Proteinuria.
Chitra PS; Swathi T; Sahay R; Reddy GB; Menon RK; Kumar PA
J Cell Biochem; 2015 Sep; 116(9):1947-56. PubMed ID: 25740786
[TBL] [Abstract][Full Text] [Related]
12. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
[TBL] [Abstract][Full Text] [Related]
13. Proteinuria: detection and role in native renal disease progression.
Gorriz JL; Martinez-Castelao A
Transplant Rev (Orlando); 2012 Jan; 26(1):3-13. PubMed ID: 22137726
[TBL] [Abstract][Full Text] [Related]
14. Non-genetic mechanisms of diabetic nephropathy.
Han Q; Zhu H; Chen X; Liu Z
Front Med; 2017 Sep; 11(3):319-332. PubMed ID: 28871454
[TBL] [Abstract][Full Text] [Related]
15. The Presence and Location of Podocytes in Glomeruli as Affected by Diabetes Mellitus.
Maraszek KE; Santo BA; Yacoub R; Tomaszewski JE; Mohammad I; Worral AM; Sarder P
Proc SPIE Int Soc Opt Eng; 2020 Feb; 11320():. PubMed ID: 32362706
[TBL] [Abstract][Full Text] [Related]
16. The structural and functional organization of the podocyte filtration slits is regulated by Tjp1/ZO-1.
Itoh M; Nakadate K; Horibata Y; Matsusaka T; Xu J; Hunziker W; Sugimoto H
PLoS One; 2014; 9(9):e106621. PubMed ID: 25184792
[TBL] [Abstract][Full Text] [Related]
17. AMPK signalling: Implications for podocyte biology in diabetic nephropathy.
Szrejder M; Piwkowska A
Biol Cell; 2019 May; 111(5):109-120. PubMed ID: 30702162
[TBL] [Abstract][Full Text] [Related]
18. The podocyte and diabetes mellitus: is the podocyte the key to the origins of diabetic nephropathy?
Reddy GR; Kotlyarevska K; Ransom RF; Menon RK
Curr Opin Nephrol Hypertens; 2008 Jan; 17(1):32-6. PubMed ID: 18090667
[TBL] [Abstract][Full Text] [Related]
19. The role of podocytes in glomerular pathobiology.
Asanuma K; Mundel P
Clin Exp Nephrol; 2003 Dec; 7(4):255-9. PubMed ID: 14712353
[TBL] [Abstract][Full Text] [Related]
20. Podocyte-specific overexpression of metallothionein mitigates diabetic complications in the glomerular filtration barrier and glomerular histoarchitecture: a transmission electron microscopy stereometric analysis.
Carlson EC; Chhoun JM; Laturnus DI; Bikash KC; Berg B; Zheng S; Epstein PN
Diabetes Metab Res Rev; 2013 Feb; 29(2):113-24. PubMed ID: 22926941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
